AR008765A1 - Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del - Google Patents
Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto delInfo
- Publication number
- AR008765A1 AR008765A1 ARP970102432A ARP970102432A AR008765A1 AR 008765 A1 AR008765 A1 AR 008765A1 AR P970102432 A ARP970102432 A AR P970102432A AR P970102432 A ARP970102432 A AR P970102432A AR 008765 A1 AR008765 A1 AR 008765A1
- Authority
- AR
- Argentina
- Prior art keywords
- composite
- same
- peptide
- recombinant
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Child & Adolescent Psychology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Un péptido o un derivado, análogo o variante funcional del mismo, que modula el peso corporal sustancialmente por medio de modulacion de lautilizacion de la energía, un péptido recombinante o sintético del mismo, una secuencia nucleotídica yvector que la contiene, una célula huéspedtransformada, una composicion farmacéutica que contiene un compuesto de este tipo, un procedimiento para la preparacionde un compuesto de este tipo y el usode dicho compuesto en medicina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9611775.9A GB9611775D0 (en) | 1996-06-06 | 1996-06-06 | Novel compounds |
| GBGB9618540.0A GB9618540D0 (en) | 1996-09-05 | 1996-09-05 | Novel compounds |
| GBGB9703493.8A GB9703493D0 (en) | 1997-02-20 | 1997-02-20 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008765A1 true AR008765A1 (es) | 2000-02-23 |
Family
ID=27268305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102432A AR008765A1 (es) | 1996-06-06 | 1997-06-04 | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0912609A2 (es) |
| JP (1) | JP2000512137A (es) |
| KR (1) | KR20000016402A (es) |
| CN (1) | CN1221426A (es) |
| AR (1) | AR008765A1 (es) |
| AU (1) | AU3337297A (es) |
| BR (1) | BR9709529A (es) |
| CA (1) | CA2257240A1 (es) |
| CZ (1) | CZ397898A3 (es) |
| IL (1) | IL127153A0 (es) |
| NO (1) | NO985683D0 (es) |
| NZ (1) | NZ332879A (es) |
| PL (1) | PL330361A1 (es) |
| TR (1) | TR199802534T2 (es) |
| WO (1) | WO1997046585A2 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
| ATE278952T1 (de) | 1998-07-28 | 2004-10-15 | Vlaams Interuniv Inst Biotech | Leptin vermittelte geninduktion |
| US7208572B2 (en) * | 1998-08-21 | 2007-04-24 | Albany Medical College | Leptin-related peptides |
| US6777388B1 (en) | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
| US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| WO2001021647A2 (en) * | 1999-09-22 | 2001-03-29 | Genset | Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| EP1612221A3 (en) | 2000-05-22 | 2008-07-23 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Receptor-based interaction trap |
| JP2005506994A (ja) | 2001-10-22 | 2005-03-10 | アムジェン インコーポレイテッド | ヒト脂肪組織萎縮症を処置するためのレプチンの使用および該処置のための素因決定方法 |
| DE602004012759T2 (de) | 2003-09-08 | 2008-07-17 | Laboratoires Serono S.A., Coinsins | Behandlung von fibrosen |
| EP2417980A1 (en) | 2004-02-11 | 2012-02-15 | Amylin Pharmaceuticals Inc. | Hybrid polypeptides with selectable properties |
| WO2006053883A1 (en) | 2004-11-18 | 2006-05-26 | Vib Vzw | Fibronectin iii domain as leptin receptor antagonists |
| BRPI0606992A2 (pt) | 2005-02-11 | 2009-07-28 | Amylin Pharmaceuticals Inc | análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis |
| US7629315B2 (en) | 2005-03-09 | 2009-12-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compositions for blocking the inhibitory effect of human CRP on human leptin |
| BRPI0614649A2 (pt) | 2005-08-11 | 2011-04-12 | Amylin Pharmaceuticals Inc | polipeptìdeos hìbridos com propriedades selecionáveis |
| EP2330124B1 (en) | 2005-08-11 | 2015-02-25 | Amylin Pharmaceuticals, LLC | Hybrid polypeptides with selectable properties |
| ES2319048B1 (es) * | 2007-06-20 | 2010-02-10 | Universitat De Les Illes Balears | Uso de leptina en el tratamiento de alteraciones en los habitos alimentarios. |
| US8889622B2 (en) | 2007-07-25 | 2014-11-18 | Washington University | Methods of inhibiting seizure in a subject |
| GB2451858A (en) * | 2007-08-15 | 2009-02-18 | Sergiy Konovchuk | Methods of reducing body fat and treating obesity |
| US7851471B2 (en) | 2007-12-05 | 2010-12-14 | Astrazeneca Ab (Publ) | Compounds I |
| BRPI0820950A2 (pt) | 2007-12-05 | 2015-07-07 | Astrazeneca Ab | Composto, formulação farmacêutica, uso de um composto, métodos para o tratamento ou prevenção de condições ou doenças e para inibição da angiogênese, e, processo para a preparação de um composto. |
| CN102143747A (zh) * | 2008-06-04 | 2011-08-03 | 阿斯利康(瑞典)有限公司 | 作为瘦蛋白受体调节剂模拟物的新的吡啶衍生物 |
| AU2009254547A1 (en) * | 2008-06-04 | 2009-12-10 | Astrazeneca Ab (Publ) | New compounds V |
| EP2416797A4 (en) | 2009-04-10 | 2013-04-24 | Amylin Pharmaceuticals Llc | AMYLINAGONIST COMPOUNDS FOR OXYGEN ANIMAL MICE |
| US9475839B2 (en) * | 2010-05-11 | 2016-10-25 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
| ES2630031T3 (es) | 2010-09-28 | 2017-08-17 | Aegerion Pharmaceuticals, Inc. | Un polipéptido de leptina pinnípedo-humano quimérico con solubilidad aumentada |
| CN104829707B (zh) * | 2015-05-06 | 2017-12-19 | 广东省生物资源应用研究所 | 一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用 |
| CN110183530A (zh) | 2019-06-21 | 2019-08-30 | 深圳市亚辉龙生物科技股份有限公司 | 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| CA2211656A1 (en) * | 1995-01-31 | 1996-08-08 | Margret B. Basinski | Anti-obesity proteins |
| US5552523A (en) * | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| AU4766596A (en) * | 1995-01-31 | 1996-08-21 | Eli Lilly And Company | Ob gene product antibodies |
| WO1996031526A1 (en) * | 1995-04-06 | 1996-10-10 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
| GB9509164D0 (en) * | 1995-05-05 | 1995-06-28 | Smithkline Beecham Plc | Novel compounds |
-
1997
- 1997-06-04 CN CN97195311A patent/CN1221426A/zh active Pending
- 1997-06-04 WO PCT/EP1997/002968 patent/WO1997046585A2/en not_active Ceased
- 1997-06-04 JP JP10500240A patent/JP2000512137A/ja active Pending
- 1997-06-04 NZ NZ332879A patent/NZ332879A/xx not_active IP Right Cessation
- 1997-06-04 AR ARP970102432A patent/AR008765A1/es unknown
- 1997-06-04 AU AU33372/97A patent/AU3337297A/en not_active Abandoned
- 1997-06-04 EP EP97929156A patent/EP0912609A2/en not_active Withdrawn
- 1997-06-04 CZ CZ983978A patent/CZ397898A3/cs unknown
- 1997-06-04 CA CA002257240A patent/CA2257240A1/en not_active Abandoned
- 1997-06-04 TR TR1998/02534T patent/TR199802534T2/xx unknown
- 1997-06-04 PL PL97330361A patent/PL330361A1/xx unknown
- 1997-06-04 KR KR1019980709976A patent/KR20000016402A/ko not_active Ceased
- 1997-06-04 IL IL12715397A patent/IL127153A0/xx unknown
- 1997-06-04 BR BR9709529A patent/BR9709529A/pt not_active Application Discontinuation
-
1998
- 1998-12-04 NO NO985683A patent/NO985683D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO985683L (no) | 1998-12-04 |
| CA2257240A1 (en) | 1997-12-11 |
| WO1997046585A2 (en) | 1997-12-11 |
| NZ332879A (en) | 2000-09-29 |
| CZ397898A3 (cs) | 1999-04-14 |
| TR199802534T2 (xx) | 1999-03-22 |
| EP0912609A2 (en) | 1999-05-06 |
| PL330361A1 (en) | 1999-05-10 |
| BR9709529A (pt) | 1999-08-10 |
| AU3337297A (en) | 1998-01-05 |
| IL127153A0 (en) | 1999-09-22 |
| JP2000512137A (ja) | 2000-09-19 |
| NO985683D0 (no) | 1998-12-04 |
| KR20000016402A (ko) | 2000-03-25 |
| WO1997046585A3 (en) | 1998-04-23 |
| CN1221426A (zh) | 1999-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008765A1 (es) | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del | |
| CO4890856A1 (es) | CICATRIZACION DE FRACTURAS USANDO ANALOGOS DE PTHrP | |
| ATE556719T1 (de) | Impfstoff gegen menschliche influenza, der vier peptide aus influenza enthält | |
| CO5700784A2 (es) | Polipeptidos de virus de papiloma humano y composiciones in- munogenas | |
| DE69417252D1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
| CO4790174A1 (es) | Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen | |
| ES2188929T3 (es) | Analogos 2-peptidicos de tipo glucagon. | |
| ATE234112T1 (de) | Periphäre verabreichung von glp-1 analogen und derivate zur reguleirung der fettleibigkeit | |
| UY23561A1 (es) | Procedimiento para la preparacion de tnf-muteinas | |
| ES2187756T3 (es) | Uso de una composicion farmaceutica que comprende un peptido supresor del apetito. | |
| ES2052729T3 (es) | Un procedimiento para aplicar un revestimiento compuesto a un sustrato. | |
| HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| ES2137182T3 (es) | Derivados recombinantes del factor viii humano. | |
| AU1633200A (en) | Human parathyroid hormone modifications, preparation and use | |
| BR9807618A (pt) | Análogo de fator xdelta, dna recombinante codificante para um análogo de fator xdelta, células transformadas, preparação, uso da mesma, e, processos para produzir uma preparação contendo análogo de fator xdelta recombinante purificado e análogo de fator xa. | |
| FI20002041A7 (fi) | Syklisiä verisuoniin vaikuttavia peptidejä | |
| AR024742A1 (es) | DERIVADOS CICLOPEPTIDICOS QUE ACTUAN COMO INHIBIDORES DE LA INTEGRINA ALFA v BETA 6, LOS MEDICAMENTOS A BASE DE ESTOS COMPUESTOS, LAS COMPOSICIONESFARMACEUTICAS QUE CONTIENEN AL MENOS UNO DE ESTOS MEDICAMENTOS, Y EL EMPLEO DE ESTOS PEPTIDOS PARA PREPARAR UN MEDICAMENTO. | |
| AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
| ES2066510T3 (es) | Nuevos polipeptidos con afinidad para lipopolisacaridos y sus usos. | |
| DK1014948T3 (da) | Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptider | |
| ES2114555T3 (es) | Nuevo interferon gamma humano recombinado. | |
| AR004497A1 (es) | Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica. | |
| MX9300558A (es) | Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene. | |
| NO993684L (no) | Peptider som omfatter et T-celle-epitop spesifikt til kollagen-II | |
| CO5271650A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |